Los puntos clave no están disponibles para este artículo en este momento.
The results provide a clearer understanding of how to interpret BPRS total and percentage reduction scores in clinical trials with patients acutely ill with schizophrenia who are experiencing positive symptoms.
Leucht et al. (Fri,) studied this question.